The ALERRT® instrument: a quantitative measure of the effort required to compromise prescription opioid abuse-deterrent tablets.

about

The ALERRT® instrument: a quantitative measure of the effort required to compromise prescription opioid abuse-deterrent tablets.

Item

http://www.wikidata.org/entity/Q44345212

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

The ALERRT® instrument: a quan ...... pioid abuse-deterrent tablets.

@en

The ALERRT® instrument: a quan ...... pioid abuse-deterrent tablets.

@nl

type

Item

label

The ALERRT® instrument: a quan ...... pioid abuse-deterrent tablets.

@en

The ALERRT® instrument: a quan ...... pioid abuse-deterrent tablets.

@nl

prefLabel

The ALERRT® instrument: a quan ...... pioid abuse-deterrent tablets.

@en

The ALERRT® instrument: a quan ...... pioid abuse-deterrent tablets.

@nl

P1476

The ALERRT® instrument: a quan ...... pioid abuse-deterrent tablets.

@en

P2093

August R Buchhalter

http://www.w3.org/2001/XMLSchema#string

Edward J Cone

http://www.w3.org/2001/XMLSchema#string

Jeffrey M Dayno

http://www.w3.org/2001/XMLSchema#string

Karsten Lindhardt

http://www.w3.org/2001/XMLSchema#string

Torben Elhauge

http://www.w3.org/2001/XMLSchema#string

P2860

Human Abuse Potential of an Abuse-Deterrent (AD), Extended-Release (ER) Morphine Product Candidate (Morphine-ADER Injection-Molded Tablets) versus Extended-Release Morphine Administered Orally in Nondependent Recreational Opioid Users.

Core outcome measures for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendations

Research design considerations for clinical studies of abuse-deterrent opioid analgesics: IMMPACT recommendations.

Assessment of a formulation designed to be crush-resistant in prescription opioid abusers.

A comparison among tapentadol tamper-resistant formulations (TRF) and OxyContin® (non-TRF) in prescription opioid abusers.

Tampering with prescription opioids: nature and extent of the problem, health consequences, and solutions.

Increases in Drug and Opioid Overdose Deaths--United States, 2000-2014.

Attractiveness of reformulated OxyContin(R) tablets: assessing comparative preferences and tampering potential.

Human Abuse Potential of an Abuse-Deterrent (AD), Extended-Release (ER) Morphine Product Candidate (Morphine-ADER Injection-Molded Tablets) vs Extended-Release Morphine Administered Intranasally in Nondependent Recreational Opioid Users.

Abuse rates and routes of administration of reformulated extended-release oxycodone: initial findings from a sentinel surveillance sample of individuals assessed for substance abuse treatment.

P304

291-298

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/00952990.2016.1278006

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28448223

http://www.w3.org/2001/XMLSchema#string